公开(公告)号：US20240360418A1

公开(公告)日：2024-10-31

申请号：US18630991

申请日：2024-04-09

申请人： SDF BioPharma Inc.

发明人： Gerald SWISS ,  David KIEWLICH

IPC分类号： C12N5/071 ,  A61K35/17 ,  A61K35/39 ,  A61P3/10 ,  C07K14/52 ,  C12N5/0781 ,  C12N5/0783

CPC分类号： C12N5/0676 ,  A61K35/17 ,  A61K35/39 ,  A61P3/10 ,  C07K14/522 ,  C12N5/0635 ,  C12N5/0638 ,  C12N5/0646 ,  C12N5/0686 ,  C12N2501/998 ,  C12N2502/11 ,  C12N2502/99 ,  C12N2510/00

摘要： Described herein are human transgenic beta cells expressing fugetactic levels of CXCL12 to a subject in need thereof. Also described herein are beta cells comprising a transgene comprising a nucleic acid sequence encoding CXCL12.